Uridine increases endurance and improves the rehabilitation of experimental animals after physical performance

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: The pharmacological correction of metabolic processes, providing an increase in the efficiency and duration of physical performance and contributing to rapid rehabilitation, is an important component of the regulation of adaptation. Previously, we found that the pyrimidine nucleoside uridine exhibits antihypoxic properties, activates mitochondrial K+ATP channels (mitoKATP), normalizes energy metabolism, reduces lipid peroxidation, activates the antioxidant system, and increases glycogen content. The substance with such properties was assumed to increase endurance and improve recovery after physical performance.

AIM: To examine the effect of uridine on the endurance of experimental animals in the forced swimming test under different intensities of physical performance and their rehabilitation.

MATERIALS AND METHODS: Experiments were performed on male Wistar rats (350–380 g) and male outbred mice (25–30 g). In the first series, the effect of uridine on the rat’s endurance was studied in the forced swimming test with a load of 5%, 7%, or 10% of the animal weight. In the second series, the effect of uridine on the first phase of recovery was evaluated in a three-load swimming test. Mice with 10% load were subjected to a swimming test three times, after which the trail index —the ratio of time of the third trail to the first trail — was determined. The frequency of animals with low, medium, and high recovery ability was estimated. Uridine 30 mg/kg or physiological saline (control) was administered 30 min before testing, 5-hydroxidecanoate (5-HD, mitoKATP blocker) 5 mg/kg 45 min before testing, and mexidol (reference drug) 200 mg/kg 50 min before testing.

RESULTS: Uridine increased the critical swimming duration by 58% and 44% at 5% and 7% exercise, respectively, in comparison with control. At 7% load, the drug increased the period before the appearance of the first signs of fatigue by 100%. After the blockade of mitoKATP channels, the effect of uridine decreased by 40% in the presence of fatigue and 24% in critical swimming duration. In the three-load swimming test, uridine increased the trail index by 1.5 times, which was comparable to the effect of mexidol, and increased the number of animals with a high ability to recover by 2.6 times. The use of uridine after mitoKATP channel blockade did not lead to a decrease of its positive effect and the blockade of channels with 5-HD did not affect rehabilitation.

CONCLUSIONS: Uridine increases the endurance of rats with a medium load in the forced swimming test and the rehabilitation of mice in the three-load swimming test. It also increases the number of animals with a high ability to recover after a swimming performance. The mechanism of its effects was realized both through the activation of mitoKATP channels and, probably, the stimulation of glycogenesis.

Full Text

Restricted Access

About the authors

Irina B. Krylova

Institute of Experimental Medicine

Author for correspondence.
Email: irinakrylova@mail.ru
ORCID iD: 0000-0002-6213-5117
SPIN-code: 7478-0420

Cand. Sci. (Biol.), Senior Researcher

Russian Federation, 12, Academika Pavlova st., Saint Petersburg, 197376

Elena N. Selina

Institute of Experimental Medicine

Email: selina.elena@mail.ru
ORCID iD: 0000-0003-4591-209X
SPIN-code: 5558-2731

Researcher

Russian Federation, 12, Academika Pavlova st., Saint Petersburg, 197376

References

  1. Gridin LA, Ikhalainen AA, Bogomolov AV, et al. Metody issledovaniya i farmakologicheskoi korrektsii fizicheskoi rabotosposobnosti cheloveka. Ushakov IB, editor. Moscow: Meditsina, 2007. 104 p. (In Russ.)
  2. Shustov EB, Kapanadze GD, Stankova NV, et al. Hypoxia of physical activity at the atlets and laboratory animals. Biomedicine. 2014;(4):4–16. (In Russ.)
  3. Li J, Li Y, Atacan MM, et al. The molecular adaptive responses of skeletal muscle to high-intensity exercise/training and hypoxia. Antioxidants (Basel). 2020;9(8):656. doi: 10.3390/antiox9080656
  4. Pitkevich EhS, Lositskii EA, Krest’yaninova TYu, Derkach IN. Farmakologicheskaya korrektsiya rabotosposobnosti v sporte. Metodicheskie rekomendatsii. Vitebsk: VGU imeni P.M. Masherova, 2013. 52 p. (In Russ.)
  5. Krylova IB, Safonova AF, Evdokimova NR. Correction of hypoxic state by metabolic precursors of endogenous activator of mitochondrial ATP-dependent K+channels. Reviews on Clinical Pharmacology and Drug Therapy. 2018;16(3):25–32. (In Russ.) doi: 10.17816/RCF16325-31
  6. Bulion VV, Krylova IB, Selina EN. Cardioprotection of ischemic myocardium. Reviews on Clinical Pharmacology and Drug Therapy. 2018;16(2):13–17. (In Russ.) doi: 10.17816/RCF16213-17
  7. Krylova IB, Selina EN, Bulion VV, et al. Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/ reperfusion by activating the mitochondrial ATPdependent potassium channel. Sci Rep. 2021;11(1):16999. doi: 10.1038/s41598-021-96562-7
  8. Bul´on VV, Krylova IB, Rodionova OM, et al. Comparative study of cardioprotective effects of uridine-5'-monophosphate and uridine-5'-triphosphate during the early periods of acute myocardial ischemia. Bull Exp Biol Med. 2007;144(3):322–325. doi: 10.1007/s10517-007-0323-4
  9. Aussedat J. Effect of uridine supply on glycogen resynthesis after ischaemia in the isolated perfused rat heart. Cardiovasc Res. 1983;17(3):145–151. doi: 10.1093/cvr/17.3.145
  10. Karkishchenko NN, Karkishchenko VN, Shustov EB, et al. Biomeditsinskoe (doklinicheskoe) izuchenie lekarstvennykh sredstv, vliyayushchikh na fizicheskuyu rabotosposobnost’. Metodicheskie rekomendatsii. Moscow: Nauchnyi tsentr biomeditsinskikh tekhnologii FMBA Rossii, 2017. 134 p. (In Russ.)
  11. Mankovskaya IN, Nosar VI, Gonchar OA, et al. The effect of uridine on the endurance of animals with different resistance to physical stress: the role of mitochondrial ATP-dependent potassium channel. Biophysics. 2014;59(5):941–945. (In Russ.)
  12. Cheetham ME, Boobis LH, Brooks S, Williams C. Human muscle metabolism during sprint running. J Appl Physiol. 1985;61(1):54–60. doi: 10.1152/jappl.1986.61.1.54
  13. Girard O, Mendez-Villanueva A, Bishop D. Repeated-sprint ability-part I: factors contributing to fatigue. Sports Med. 2011;41(8): 673–694. doi: 10.2165/11590550-000000000-00000
  14. Burke LM, van Loon LJC, Hawley JA. Postexercise muscle glycogen resynthesis in humans. J Apl Physiol. 2017;122(5):1055–1067. doi: 10.1152/japplphysiol.00860.2016
  15. American College of Sports Medicine. ACSM’s advanced exercise physiology. 2nd ed. Farrell PA, Joyner M, Caiozzo V, editors. Wolters Kluwer Health/Lippincott Williams and Wilkins, 2012. 719 p.
  16. Bul´on VV, Krylova IB, Selina EN, et al. Antiarrhythmic effect of uridine and uridine-5'-monophosphate in acute myocardial ischemia. Bull Exp Biol Med. 2014;157(6):728–731. doi: 10.1007/s10517-014-2653-3
  17. Katz A. A century of exercise physiology: key concepts in regulation of glycogen metabolism in skeletal muscle. Eur J Appl Physiol. 2022;122(8):1751–1772. doi: 10.1007/s00421-022-04935-1

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 84654 от 01.02.2023 г

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies